295 results on '"Cock, Ian Edwin"'
Search Results
2. Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis
- Author
-
Courtney, Reece and Cock, Ian Edwin
- Published
- 2022
- Full Text
- View/download PDF
3. Antibacterial Activity and Toxicity Profiles of Selected Medicinal Plant Extracts and Conventional Antibiotics against Bacterial Triggers of Some Autoimmune Diseases.
- Author
-
Cocis, Amadeus and Cock, Ian Edwin
- Subjects
- *
RHEUMATIC fever , *ANTIBACTERIAL agents , *PLANT extracts , *ANTI-infective agents , *MULTIPLE sclerosis - Abstract
Background: Nigella sativa L., Anongessius latifolia (Roxb. ex DC.) Wall. ex Euill. and Perr. and shilajit have been used traditionally to treat numerous infectious diseases, including many caused by bacterial pathogens. However, extracts of these traditionally medicines have been poorly studied and are yet to be tested for the ability to inhibit the growth of bacterial triggers of multiple sclerosis and rheumatic fever. Materials and Methods: Antimicrobial activity of selected plant extracts was assessed using disc diffusion and liquid dilution minimum inhibitory concentration (MIC) assays against some bacterial triggers of multiple sclerosis and rheumatic fever. Interactions between the extracts and conventional antibiotics were studied and classified using the sum of the fractional inhibitory concentration (SFIC). The toxicity of the individual samples and the combinations was assessed using the artemia lethality assay (ALA) assay. Results: The methanolic A. latifolia extract displayed notable antibacterial activity against the bacterial triggers of multiple sclerosis (A. baylyi and P. aeruginosa), and rheumatic fever (S. pyogenes). Furthermore, combining the methanolic A. latifolia extract with tetracycline and chloramphenicol resulted in potentiation of the inhibitory activity against P. aeruginosa and S. pyogenes. None of the individual components (nor the combinations) were toxic in the ALA assay. Conclusion: The A. latifolia methanolic displayed clinically relevant antibacterial activity against A. baylyi, P. aeruginosa and S. pyogenes when tested alone. Furthermore, that extract also potentiated the activity of tetracycline and chloramphenicol against some bacteria. The lack of toxicity of the extracts and combinations indicates that these combinations may provide leads in the development of new therapies to prevent and treat the autoimmune diseases multiple sclerosis and rheumatic fever. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Eucalyptus major (Maiden) Blakely and Melaleuca alternifolia (Maiden and Betche) Cheel Leaf Solutions Inhibit the Growth of Antibiotic-Sensitive and ß-Lactam Resistant Bacterial Pathogens.
- Author
-
Dumont, Eléonore, Cordon, Marie-Alisabeth, Baghtchedjian, Linn, Zai, Muhammad Jawad, and Cock, Ian Edwin
- Subjects
DRUG resistance in bacteria ,MULTIDRUG resistance in bacteria ,ESCHERICHIA coli ,DRUG resistance ,ANTIBACTERIAL agents ,METHICILLIN-resistant staphylococcus aureus ,KLEBSIELLA pneumoniae ,EUCALYPTUS - Abstract
Background: The increased prevalence of antibiotic-resistant bacterial pathogens has substantially decreased the efficacy of some antibiotics and has rendered others completely ineffective. Widespread bacterial resistance to ß-lactam antibiotics (including resistance to the second-generation drug methicillin) is particularly concerning and new antibiotic therapies are urgently needed. Materials and Methods: The antibacterial activity of commercially sourced water-soluble Eucalyptus major and Melaleuca alternifolia leaf solutions was screened against ß-lactam resistant and sensitive bacterial strains of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus using disc diffusion assays. The activity was quantified by broth microdilution minimum inhibitory concentration (MIC) assays. Toxicity was evaluated by testing Artemia nauplii mortality assays. Results: Methanolic and aqueous extracts prepared from Eucalyptus major and Melaleuca alternifolia leaves displayed noteworthy growth inhibitory activity against all of the bacteria tested, including against methicillin resistant Staphylococcus aureus MRSA and extended spectrum ß-lactamase (ESBL) strains of E. coli and K. pneumoniae. The methanolic E. major leaf extract had particularly good antibacterial activity (MICs=39-625 µg/mL) against all bacterial strains. Notably, this extract had similar potency against an ESBL strain of E. coli as against the corresponding antibiotic-sensitive strain (MICs=78 µg/mL against each) and was significantly more potent against an ESBL K. pneumoniae strain (MIC=39 µg/mL) than against the corresponding antibiotic sensitive strain (MIC=78 µg/mL). All extracts were non-toxic in the Artemia nauplii lethality assay (ALA), indicating their safety for topical use. Conclusion: The potency of the E. major and M. alternifolia extracts against multi-antibiotic resistant bacteria and their lack of toxicity highlight these species as potential targets for antibiotic drug development. Further phytochemical and mechanistic studies of these species are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. An Assessment of the Antibacterial Activities, Phytochemistry and Toxicities of Nigella damascena L. Seed Extracts.
- Author
-
Jinwoo Kim, Rusford, Enoch John, Tiwana, Gagan, Alcorn, Sean Robert, Cock, Ian Edwin, and Cheesman, Matthew James
- Subjects
DRUG resistance in bacteria ,METHICILLIN-resistant staphylococcus aureus ,ARTEMIA ,BACTERIAL growth ,PHYTOCHEMICALS ,NATURAL products - Abstract
Background: Nigella damascena L. (ND) seeds have been incorporated into traditional plant-based medicinal systems for millennia. However, there are conflicting reports on the antibacterial activities of the seed extracts, although phytochemicals known to possess antibacterial activity have been found in the seeds of this species. The toxicities of the extracts have not been studied previously. Aim: This work assesses the ability for aqueous and methanolic ND seed extracts to inhibit the growth of a panel of skin pathogens on agar and in broth, including methicillin-resistant Staphylococcus aureus (MRSA). Qualitative determinations of the phytochemical constituents of the extracts were performed, as well as their toxicity levels. Materials and Methods: Bacterial growth inhibition was evaluated using agar disc diffusion and liquid broth microdilution assays, whilst Artemia nauplii bioassays were used to screen toxicities. Qualitative phytochemical assays were conducted to assess the relative abundance of several important phytochemical compound classes. Results: No inhibition was observed on agar for either the aqueous or methanolic extracts against S. aureus, MRSA, S. epidermidis or S. pyogenes. This was concordant with the liquid microdilution broth assays, with the exception of the methanolic ND extract against S. pyogenes, which produced a minimum inhibitory concentration value of 481 µg/mL. Phenols, saponins, tannins and alkaloid were present in both extract types, while flavonoids could be detected in the methanolic extract only. Both extracts were deemed to be nontoxic in the Artemia nauplii assay. Conclusion: The ND methanolic extract possessed activity against S. pyogenes in liquid broth, but not on agar. The presence of flavonoids in this extract may be responsible for this activity. The extracts were inactive against S. aureus, MRSA and S. epidermidis in agar and broth assays, and were also nontoxic as adjudged by the Artemia nauplii brine shrimp assays. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Taraxacum officinale (L.) Weber ex F.H. Wigg Root Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases and Potentiate the Activity of Conventional Antibiotics.
- Author
-
Biao Chen, Yelu Liu, and Cock, Ian Edwin
- Subjects
PLANT extracts ,COMMON dandelion ,RHEUMATOID arthritis ,ANKYLOSING spondylitis ,AUTOIMMUNE diseases - Abstract
Introduction: An increase in antibiotic resistance and a corresponding decrease in antimicrobial discovery have directed researchers towards alternative therapies, including plant-based medicines. However, synergistic combinations of plant extracts with conventional antibiotics may be a far more effective approach in overcoming resistance and potentiating the activity of antibiotics that are otherwise ineffective against resistant bacterial strains. Materials and Methods: The antibacterial activity of Taraxacum officinale (L.) Weber ex F.H. Wigg. root extracts was investigated by disc diffusion and quantified by liquid dilution and solid phase MIC assays against some bacterial triggers of autoimmune inflammatory diseases. The extracts were also combined with a range of conventional antibiotics and tested against various bacterial pathogens. The SFIC values obtained from these assays were used to determine the class of combinational effects. Toxicity was evaluated by Artemia nauplii mortality and HDF cytotoxicity assays. Results: Methanolic and ethyl acetate T. officinale root extracts showed good inhibitory activity against several microbial triggers of autoimmune inflammatory diseases, including P. mirabilis, P. vulgaris and A. baylyi. Of further interest, some combinations of the T. officinale root extracts and conventional antibiotics potentiated bacterial growth inhibition compared to the individual components alone. Six synergistic and seven additive interactions were noted. Additionally, two antagonistic interactions were evident, indicating that those combinations should be avoided. All extracts were nontoxic in the ALA and HDF assays, verifying their safety for therapeutic usage. Conclusion: Taraxacum officinale root extracts have potential as inhibitors of bacterial triggers of selected autoimmune inflammatory diseases. Furthermore, extract components may also potentiate the activity of three antibiotics that are relatively ineffective alone. Isolation and identification of these compounds may be beneficial in drug design against several bacteria, including the microbial triggers of rheumatoid arthritis and multiple sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
- Author
-
Chintalaramulu, Naveen, Vadivelu, Raja, Nguyen, Nam-Trung, and Cock, Ian Edwin
- Published
- 2020
- Full Text
- View/download PDF
8. An Electrolytically Prepared Colloidal Silver Preparation Protects against Citrate-induced Toxicity in Artemia franciscana Nauplii.
- Author
-
Cock, Ian Edwin and Whitehouse, Michael
- Subjects
- *
COLLOIDAL silver , *CITRATES , *ARTEMIA , *POISONS , *TANNINS , *CHEMICAL synthesis - Abstract
Introduction: Nanotechnology is promising for the development of new effective medicines. Silver nanoparticle preparations have been particularly well studied and a range of beneficial effects have been identified. Despite this, the sale of Colloidal silver (CS) preparations for therapeutic purposes has been banned by multiple regulatory authorities (including the FDA and TGA) on the basis of their perceived toxicity. This study evaluates the toxicity of electrolytically produced (CS) preparation, as well as some compounds used to produce CS by chemical synthesis. Materials and Methods: Toxicity of the CS preparation and the chemical toxins were evaluated using the Artemia nauplii toxicity assay. Additionally, the CS was tested for its protective effects against citrate and tannic acid-induced toxicity by screening combinations of CS and the toxins. Results: The CS preparation was nontoxic in the Artemia nauplii bioassay at all concentrations tested and did not induce mortality substantially above the seawater control at all concentrations ≤50 μg/mL. In contrast, citrate and tannic acid were strongly toxic, with LC50 values of 11.6 and 26.8 μg/mL respectively. Interestingly, co-incubation of varying concentrations of the CS preparation with 30 μg/mL of citrate resulted in protection against toxicity, with 50 μg/mL CS inhibiting ~65% of citrate-induced toxicity. In contrast, the CS preparation had no apparent effects on tannic acid-induced toxicity. Conclusion: The CS preparation tested in our study was nontoxic at all concentrations tested. Furthermore, the CS mitigated the toxic effects of citrate, but had no apparent effect on tannic acid-induced toxicity. Further studies are required to verify these findings in other toxicity models and to study the protective molecular mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Antibacterial Activity and an Upscaled Extraction Protocol for Terminalia ferdinandiana Exell. Leaves.
- Author
-
Haokang Xu and Cock, Ian Edwin
- Subjects
- *
SUPERCRITICAL fluid extraction , *TERMINALIA , *ANTIBACTERIAL agents , *BERRIES , *SOLVENT extraction , *ENDEMIC plants , *BACTERIAL growth - Abstract
Background: Terminalia ferdinandiana Exell. is an endemic Australian plant with a high anti-oxidant capacity. Liquid solvent extractions of T. ferdinandiana leaves are strong inhibitors of the growth of numerous bacterial pathogens. Despite these promising therapeutic properties, methods for the rapid extraction of large quantities of T. ferdinandiana leaves are lacking. This study aimed to develop a rapid supercritical extraction method to produce extracts which retain therapeutic properties and phytochemistry characteristics. Materials and Methods: Terminalia ferdinandiana leaves were extracted by both solvent maceration extraction and Supercritical fluid extraction (SCE). The extracts were tested for the ability to inhibit bacterial growth using the disc diffusion assay. The antibacterial potency was further quantified using liquid dilution MIC assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay and GC-MS headspace analysis was used to evaluate phytochemical similarity between the extracts. Results: Terminalia ferdinandiana leaf SCE displayed strong bacterial growth inhibitory activity against bacterial triggers of autoimmune inflammatory diseases, with efficacies similar to the smaller laboratory scale methanolic liquid extractions. The growth inhibition of the ethyl acetate and methanolic solvent extracts and the SCE were particularly noteworthy against P. mirabilis (MICs = 128, 227 and 208μg/mL respectively) and A. baylyi (MICs = 452, 780 and 104 μg/mL respectively). GC-MS analysis of the berry SCE revealed similar terpenoid components and similar abundances to those in methanolic solvent leaf extraction. Furthermore, all liquid extracts and the SCE were non-toxic in the Artemia franciscana toxicity assay. Conclusion: The T. ferdinandiana SCE retained the tested therapeutic properties, was non-toxic and had similar phytochemical profiles as the smaller scale liquid solvent extractions. Thus, SCE is a viable method of rapidly extracting large masses of T. ferdinandiana leaves to produce quality extracts that retain therapeutic properties. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Comparison of the Antibacterial Activities of Terminalia ferdinandiana Exell. Growing in Geographically Distinct Regions of Australia.
- Author
-
Jinwoo Kim, Rusford, Enoch John, Tiwana, Gagan, Alcorn, Sean Robert, Cock, Ian Edwin, and Cheesman, Matthew James
- Subjects
ANTIBACTERIAL agents ,TERMINALIA ,FRUIT extracts ,VITAMIN C ,MEDICINAL plants - Abstract
Background: Terminalia ferdinandiana Exell. fruit have been used by the First Australians as a nutritious food and as a medicine for thousands of years. The antibacterial properties of T. ferdinandiana fruit extracts are well reported. However, the therapeutic potential of plants growing in different locations and environmental conditions have not previously been compared. Aim: This study compares the antibacterial efficacy of fruit harvested from two distinct locations in Australia and correlates these activities with their physiochemical properties. Materials and Methods: The growth inhibitory activity of the T. ferdinandiana fruit extracts were evaluated using solid phase disc diffusion and liquid microdilution MIC assays. Artemia nauplii bioassays were used to screen and compare the extracts from both locations. Results: The T. ferdinandiana extracts prepared from fruits sourced from the two distinct regions of Australia inhibited the growth of the panel of bacteria screened, including a highly antibiotic MRSA strain. In general, the methanolic extracts were substantially better inhibitors of bacterial growth than the aqueous extracts, and extracts prepared using the Northern Territory (NT)-derived fruit were substantially more potent than the Western Australian (WA) fruit extracts. MICs substantially <1000 μg/mL were noted for the NT methanolic fruit extract against the reference S. aureus and MRSA bacterial strains respectively. The potency of this extract against the MRSA strain indicates that this extract may function via a distinct mechanism compared to the standard antibiotics tested. Interestingly, the greater antibacterial potency of the NT fruit extracts correlated to high ascorbic acid levels, indicating that the antibacterial mechanism may involve modulation of the redox state. All extracts were nontoxic in the Artemia nauplii toxicity assay, indicating their safety for therapeutic usage. Conclusion: The T. ferdinandiana fruit extracts prepared from both NT and WA each had noteworthy antibacterial activity, although greater activity was noted for the NT fruit extracts. This activity correlated with the antioxidant/ascorbic acid content of the extracts. All extracts were also nontoxic in the Artemia nauplii bioassay, although future studies using mammalian cell lines are required to confirm their safety for therapeutic use. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Podocarpus latifolius (Thunb.) R.Br. ex Mirb. Extracts Inhibit the Growth Some Bacterial Triggers of Rheumatoid Arthritis and Ankylosing Spondylitis.
- Author
-
Mpala, Lindiwe Nomathemba, Chikowe, Getmore Rumbudzai, and Cock, Ian Edwin
- Subjects
ANKYLOSING spondylitis ,RHEUMATOID arthritis ,TYPHA latifolia ,BACTERIAL growth ,AUTOIMMUNE diseases ,LEAF growth ,SOLVENT extraction - Abstract
Introduction: Podocarpus latifolius (Thunb.) R.Br. ex Mirb. is a large tree that is native to southern Africa. This species has been used extensively for multiple therapeutic purposes across the southern part of the African continent. Despite this, P. latifolius leaf extracts have not been rigorously examined growth inhibitory properties against many bacteria, including the bacterial triggers of autoimmune inflammatory diseases. Materials and Methods: The antimicrobial activity of P. latifolia leaf solvent extractions was investigated by disc diffusion and growth time course assays against some bacterial triggers of rheumatoid arthritis and ankylosing spondylitis. The growth inhibitory activity was further quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous P. latifolia leaf extracts were good inhibitors of P. mirabilis and K. pneumoniae. The inhibitory activity of both extracts was particularly noteworthy against the bacterial trigger of ankylosing spondylitis (K. pneumonia), with MICs of 343 and 557 µg/mL determined for the methanolic and aqueous extracts respectively. The extracts also displayed noteworthy activity against a bacterial trigger of rheumatoid arthritis (P. mirabilis), with MICs of 580 and 634 µg/mL respectively. The antibacterial activity of the methanolic and aqueous P. latifolia leaf extracts were further investigated by growth time course assays, which showed significant growth inhibition in cultures of P. mirabilis and K. pneumoniae within 1 hr of exposure. The extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for prophylactic use in preventing these autoimmune inflammatory diseases. Conclusion: The lack of toxicity of the P. latifolia leaf extracts and their growth inhibitory bioactivity against the bacterial triggers of rheumatoid arthritis and ankylosing spondylitis indicate their potential in the development of new therapies targeting the onset of these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Phytochemical Evaluation of Terminalia canescens DC. Radlk. Extracts with Antibacterial and Antibiotic Potentiation Activities against Selected β-Lactam Drug-Resistant Bacteria.
- Author
-
Zai, Muhammad Jawad, Cheesman, Matthew James, and Cock, Ian Edwin
- Subjects
LACTAMS ,TANNINS ,TERMINALIA ,LIQUID chromatography-mass spectrometry ,PLANT extracts ,ELLAGIC acid ,ANTIBIOTICS - Abstract
Terminalia canescens DC. Radlk. (family: Combretaceae) is native to northern Australia. Species of the genus Terminalia are widely used as traditional medicines to treat diverse ailments, including bacterial infections. However, we were unable to find any studies that had examined the antimicrobial activity of T. canescens. In this study, T. canescens was screened against a panel of bacterial pathogens, including multi-antibiotic-resistant strains. Solvents with different polarities were used to extract different complements of phytochemicals from T. canescens leaves. Methanolic and aqueous extracts exhibited substantial antimicrobial activity against various pathogens, including those that are multidrug-resistant strains. When combined with some selected clinical antibiotics, some extracts potentiated the antibacterial inhibitory activity. This study identified two synergistic, eleven additive, eleven non-interactive and eight antagonistic interactions. The toxicities of the plant extracts were examined in the Artemia franciscana nauplii assay and were found to be non-toxic, except the aqueous extract, which showed toxicity. Metabolomic liquid chromatography–mass spectrometry (LC-MS) analyses highlighted and identified several flavonoids, including vitexin, quercetin, orientin and kaempferol, as well as the tannins ellagic acid and pyrogallol, which may contribute to the antibacterial activities observed herein. The possible mechanism of action of these extracts was further explored in this study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Selected Australian Terminalia Species Extracts Inhibit β-Lactam Drug-Resistant Bacteria Growth and Potentiate the Activity of Conventional Antibiotics: Bioactivities and Phytochemistry.
- Author
-
Zai, Muhammad Jawad, Cheesman, Matthew James, and Cock, Ian Edwin
- Subjects
FRUIT extracts ,LACTAMS ,TERMINALIA ,LIQUID chromatography-mass spectrometry ,BOTANICAL chemistry ,ETHYL acetate ,EXTRACTS - Abstract
Terminalia ferdinandiana Exell, Terminalia grandiflora Benth., Terminalia microcarpa Decne., and Terminalia muelleri Benth. (family: Combretaceae) belong to the genus Terminalia. Plants of this genus have been extensively used as traditional medicines to treat a variety of illnesses, including pathogen infections. However, we were unable to find any studies that have investigated the antibacterial activity of T. microcarpa. Similarly, whilst some preliminary studies have examined the antimicrobial properties of T. muelleri and T. grandiflora, they did not test the extracts against antibiotic-resistant pathogens. This study screens the antimicrobial activity of T. grandiflora, T. microcarpa, and T. muelleri and compares it to that of T. ferdinandiana extracts prepared from both the fruit and leaves against a range of pathogens, including multi-antibiotic-resistant strains. Solvents with varying polarities were used to extract different phytochemical constituents from the leaves of T. grandiflora, T. microcarpa, and T. muelleri and from the fruit and leaves of T. ferdinandiana. The aqueous and methanolic extracts each displayed significant antimicrobial activity when tested against the bacterial pathogens, including against the multidrug-resistant strains. When these extracts were tested in combination with selected antibiotics, some extracts potentiated the antimicrobial activity. This study identifies twelve synergistic, fifty-eight additive, and sixty non-interactive combinations, as well as thirty antagonistic effects. The extracts were evaluated for toxicity using the Artemia franciscana nauplii lethality assay (ALA) and were each classified as non-toxic, with the exception of the methanolic and aqueous T. ferdinandiana fruit extracts and the aqueous and ethyl acetate T. ferdinandiana leaf extracts. Metabolomic analysis using liquid chromatography–mass spectrometry (LC-MS) highlighted several flavonoids and tannins that may contribute to the antimicrobial activities reported herein. The potential antibacterial mechanism(s) of the T. ferdinandiana extracts are discussed in this study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline
- Author
-
Mandeville, Aaron and Cock, Ian Edwin
- Published
- 2018
- Full Text
- View/download PDF
15. Taraxacum officinale (L.) Weber ex F.H.Wigg Root Extracts Inhibit the Growth Gastrointestinal Bacterial Pathogens and Potentiate the Activity of Conventional Antibiotics.
- Author
-
Yixue Jiang and Cock, Ian Edwin
- Subjects
- *
PLANT extracts , *COMMON dandelion , *BACTERIAL growth , *ANTIBIOTICS , *ANTIBACTERIAL agents , *ETHYL acetate , *CARIOGENIC agents - Abstract
Introduction: An increase in antibiotic resistance and a corresponding decrease in antimicrobial discovery have directed researchers towards alternative therapies, including plant-based medicines. However, synergistic combinations of plant extracts with conventional antibiotics may be a far more effective approach in overcoming resistance and potentiating the activity of antibiotics that are otherwise ineffective against resistant bacterial strains. Materials and Methods: The antibacterial activity of Taraxacum officinale (L.) Weber ex F.H. Wigg root extracts was investigated by disc diffusion assays and quantified by liquid dilution and solid phase MIC assays. The extracts were also combined with a range of conventional antibiotics and tested against gastrointestinal disease-causing bacteria. The ΣFIC values obtained from these assays were used to determine the class of combinational effects. Toxicity was evaluated by Artemia nauplii mortality and HDF cytotoxicity assays. Results: Methanolic, aqueous and ethyl acetate T. officinale root extracts showed good inhibitory activity against several gastrointestinal bacterial pathogens. The methanolic were particularly good inhibitors of S. sonneii and S. newport, with MIC values in the range 400-450 μg/mL, whilst the ethyl acetate extract was the most potent inhibitor of S. newport growth (MIC=128 μg/mL). Of further interest, some combinations of the T. officinale root extracts and conventional antibiotics potentiated bacterial growth inhibition compared to the individual components. Five synergistic and two additive interactions were noted. Interestingly, only a single antagonistic interaction was evident, indicating that nearly all combinations could be used without decreasing the antibacterial activity of the components. All extracts were nontoxic in the ALA and HDF assays. Conclusion: Taraxacum officinale root extracts have potential as inhibitors of bacterial gastrointestinal pathogens. Furthermore, extract components may also potentiate the activity of some antibiotics that are relatively ineffective alone. Isolation and identification of these compounds may be beneficial in drug design against several gastrointestinal bacterial pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. A Review of the Ethnobotany, Phytochemistry and Medicinal Properties of Australian Terminalia Species.
- Author
-
Yousaf Zai, Muhammad Jawad, Cheesman, Matthew James, and Cock, Ian Edwin
- Subjects
TERMINALIA ,DRUG discovery ,ETHNOBOTANY ,DRUG design ,SPECIES ,ANTIFUNGAL agents ,BOTANICAL chemistry ,ANTIDIARRHEALS - Abstract
The genus Terminalia contains some of the most widely used plants in traditional medicine. Many species possess antifungal, antibacterial, antiviral, antiprotozoal, analgesic, antidiarrheal, antioxidant, antimalarial, anticancer, and anti-inflammatory properties. Some species also have cardiovascular and wound-healing effects. Despite their myriad of traditional uses, relatively few studies have examined the medicinal properties and phytochemistry of most Australian Terminalia spp. The high tannin content of Terminalia spp. has been postulated to be a major contributor to the medicinal properties of this important genus. However, the complexities of tannins are generally believed to make them a poor choice for drug design. Therefore, much of the interest in Terminalia species has been for their nutraceutical and pharmacognostic value, and they remain under-explored in terms of drug discovery. Recent studies have identified many other important phytochemicals within Terminalia species apart from the tannins and have established that these compounds may contribute to their therapeutic bioactivities. Several Australian Terminalia species (particularly Terminalia carpentariae C.T. White, Terminalia catappa L., Terminalia ferdinandiana Exell and Terminalia grandiflora Benth) have received the most attention due to their reported high antioxidant contents. In contrast, other Australian Terminalia spp. have been relatively ignored. This review discusses recent studies into the phytochemistry, medicinal properties and the underlying therapeutic mechanisms of Australian Terminalia species to help direct future areas of research into this important genus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Terminalia petiolaris A.Cunn ex Benth. Extracts Have Antibacterial Activity and Potentiate Conventional Antibiotics against β-Lactam-Drug-Resistant Bacteria.
- Author
-
Zai, Muhammad Jawad, Cheesman, Matthew James, and Cock, Ian Edwin
- Subjects
TERMINALIA ,ANTIBACTERIAL agents ,LIQUID chromatography-mass spectrometry ,PLANT extracts ,ETHYL acetate ,GRAM-positive bacteria - Abstract
Terminalia petiolaris A. Cunn. Ex Benth. (genus: Terminalia, family: Combretaceae) is native to Australia. Terminalia spp. have traditionally been used to treat various ailments, including bacterial infections. Solvents of varying polarity were used to extract compounds from leaves of this species, and the extracts were tested against a panel of bacteria, including antibiotic-resistant strains. The methanolic and water extracts showed substantial inhibitory activity against several bacteria, including antibiotic-resistant strains in both disc diffusion and liquid dilution assays. Combining these extracts with selected conventional antibiotics enhanced the inhibition of bacterial growth for some combinations, while others showed no significant interaction. In total, two synergistic, twenty-five additive, twenty-three non-interactive and one antagonistic interaction were observed. The methanolic and ethyl acetate plant extracts were found to be non-toxic in Artemia franciscana nauplii toxicity assays. A liquid chromatography–mass spectrometry metabolomics analysis identified several flavonoid compounds, including miquelianin, trifolin and orientin, which might contribute to the observed activities. The potential modes of these active extracts are further discussed in this study. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Shadowed by Giants: Desert Plants Versus Rainforest Plants as Targets for Novel Antibacterial Drug Discovery.
- Author
-
Wright, Mitchell Henry and Cock, Ian Edwin
- Subjects
- *
DRUG discovery , *DESERT plants , *RAIN forests , *DRUG resistance in bacteria , *EMERGING infectious diseases , *ANTIBIOTIC residues , *ECOSYSTEMS , *BIODIVERSITY - Abstract
The escalating global crisis of bacterial resistance to antibiotics poses a threat to public health. Urgent measures are required to identify novel antibacterial treatments. Multidrug-resistant bacterial strains limit the effective therapeutic options available, raising concerns about a post-antibiotic era and a reduced ability to treat infections that were previously not classified as serious. Simultaneously, the threat of emerging infectious diseases, including zoonotic pathogens, underscores the need to develop effective antibiotics against these pathogens. Innovative approaches to antibiotic development, such as novel chemical scaffolds, combination therapies, antimicrobial peptides, and phage therapy, show promise but require the discovery of new antibacterial compounds. Desert and rainforest ecosystems, despite being disparate in climate and biodiversity, offer unique prospects for developing antibacterial compounds. Deserts, which are characterized by extreme aridity and temperature fluctuations, harbor plants and micro-organisms with specialized antibacterial defences honed through evolution. Conversely, rainforests, with their biodiversity and high humidity, are promising for the development of potential antibacterial compounds. To date, much natural product research aimed at discovery of new antibiotic compounds has focussed on rainforest plants due to the biodiversity of these ecosystems, and because plants develop chemical defences against microbes that are prevalent in those environments. In comparison, the search for new antimicrobial compounds from desert plants has been overshadowed, despite some noteworthy antibacterial activities in arid environment plants. This commentary discusses the comparative potential of desert and rainforest ecosystems as reservoirs of novel antibacterial agents and emphasises the importance of screening plants in both environments. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Anti-microbial Activity of Rubus idaeus L. Leaf Extracts in Combination with Antibiotics against Bacterial Triggers of Selected Autoimmune Diseases.
- Author
-
Chen Zhang and Cock, Ian Edwin
- Subjects
- *
AUTOIMMUNE diseases , *ANTI-infective agents , *RUBUS , *MORNING sickness , *RHEUMATOID arthritis , *INTERFERON beta 1b , *ETHYL acetate - Abstract
Background: Rubus idaeus L. leaves have been used in traditional healing systems for the treatment of morning sickness, easing labour pains and for preventing miscarriage. Whilst few studies have examined the leaves of this species for therapeutic properties, the fruit have antibacterial activity against multiple bacterial pathogens. This study examines the growth inhibitory effects of R. idaeus leaf extracts, both alone and in combination with conventional antibiotics against bacterial triggers of selected autoimmune inflammatory diseases. Results: Rubus idaeus leaf extracts displayed noteworthy antibacterial activity against several bacterial triggers of autoimmune diseases. The methanolic, aqueous and ethyl acetate extracts were particularly good inhibitors of P. mirabilis, A. baylyi and P. aeruginosa growth, with MIC values as low as 53 µg/mL. Combining the extracts with conventional antibiotics potentiated the inhibitory activity for several combinations containing chloramphenicol or gentamicin against A. baylyi. Interestingly, the other combinations were generally non-interactive and no antagonistic interactions were detected, indicating that all combinations can be used without decreasing the efficacy of the therapy. None of the individual components (or the combinations) were toxic in the ALA assay. Conclusion: Rubus idaeus leaf extracts have potential for the prevention and treatment of rheumatoid arthritis and multiple sclerosis when used alone. Furthermore, some combinations of the extracts and conventional antibiotics had greater potency against the bacterial triggers of multiple sclerosis, indicating they may be beneficial for prophylactic therapy in individuals genetically predisposed to that disease [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. A Review of Ayurvedic Principles and the use of Ayurvedic Plants to Control Diarrhoea and Gastrointestinal Infections.
- Author
-
Tiwana, Gagan, Cock, Ian Edwin, and Cheesman, Matthew James
- Subjects
- *
DIARRHEA , *CHILD mortality , *TERMINALIA chebula , *DRIED fruit , *AYURVEDIC medicine - Abstract
According to the World Health Organisation (WHO), diarrhoea is the second leading cause of death in children under the age of five. It is a common symptom associated with gastrointestinal bacterial infections. Many antibiotics have lost their efficacy due to the rapid emergence of Antimicrobial Resistant (AMR) bacterial pathogens. Traditional Ayurvedic medicinal plants are likely to play a significant role in the development of new effective and safe therapies in the fight against AMR in gastrointestinal bacteria. Recent research has reported the effectiveness of numerous different Ayurvedic medicines in the treatment of gastrointestinal infections. One example is Triphala, which is a polyherbal formulation consisting of an equal mixture of dried fruit powders from the three Ayurvedic plants Terminalia bellirica (Gaertn.) Roxb., Terminalia chebula Retz. and Emblica officinalis Linn. This review discusses the principles of Ayurveda and summarises the traditional use of Ayurvedic plants in the treatment of diarrhoea, dysentery, and stomach discomfort. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Phragmites australis (Cav.) Trin. Ex Steud. Leaf Extracts Lack Anti-bacterial Activity and are Non-toxic in vitro.
- Author
-
Chikowe, Getmore Rumbudzai, Mpala, Lindiwe Nomathemba, and Cock, Ian Edwin
- Subjects
PHRAGMITES ,PHRAGMITES australis ,ANTIBACTERIAL agents ,DRUG resistance in bacteria ,DRUG discovery ,AROMATIC plants - Abstract
Introduction: The recent development of extensively antibiotic resistant bacteria has necessitated the search for novel anti-bacterial compounds. An examination of aromatic plants and traditional medicines is an attractive option for drug discovery. Phragmites australis (Cav.) Trin. Ex Steud. Reed is native to many regions globally, including Australia. It has yet to be tested for antibacterial activity. Materials and Methods: The ability of P. australis leaf extracts to inhibit the growth of a panel of bacterial pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: P. australis leaf methanolic and aqueous extracts were completely ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria. The extracts were nontoxic in the Artemia nauplii bioassay following 24 hr exposure. Conclusion: P. australis leaf extracts were completely ineffective bacterial growth inhibitors. However, these extracts may have other therapeutic properties and testing against protozoa, virus and tumour cells is required. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Inhibition of Shewanella spp. growth by Syzygium australe and Syzygium luehmannii extracts: natural methods for the prevention of fish spoilage
- Author
-
Murhekar, Shweta, Wright, Mitchell Henry, Greene, Anthony Carlson, Brownlie, Jeremy Colin, and Cock, Ian Edwin
- Published
- 2017
- Full Text
- View/download PDF
23. Therapeutic Potential of Arctium lappa L. Root Extracts to Inhibit Gastrointestinal Bacterial Pathogens and Treat Gastrointestinal Disease.
- Author
-
Cheng Mingji and Cock, Ian Edwin
- Subjects
- *
PLANT extracts , *GASTROINTESTINAL diseases , *ANTIBACTERIAL agents , *DRUG design , *CYTOTOXINS , *ETHYL acetate , *BACILLUS cereus - Abstract
Introduction: An increase in antibiotic resistance and a corresponding decrease in antimicrobial discovery have directed researchers towards alternative therapies, including plant based medicines. However, synergistic combinations of plant extracts with conventional antibiotics may be a far more effective approach in overcoming resistance and potentiating the activity of antibiotics that are otherwise ineffective against resistant bacterial strains. Materials and Methods: The antibacterial activity of Arctium lappa L. root extracts was investigated by disc diffusion and quantified by liquid dilution and solid phase MIC assays. The extracts were also combined with a range of conventional antibiotics and tested against various microbial triggers of autoimmune diseases. The ΣFIC values obtained from these assays were used to determine the class of combinational effects. Toxicity was evaluated by Artemia nauplii mortality and HDF cytotoxicity assays. Results: Methanolic and ethyl acetate A. lappa root extracts showed good inhibitory activity against several gastrointestinal bacterial pathogens. They were particularly good inhibitors of S. sonneii and B. cereus, with MIC values in the range 150-250μg/mL. The aqueous extract was also a noteworthy inhibitor of B. cereus growth. Of further interest, some combinations of the A. lappa root extracts and conventional antibiotics potentiated bacterial growth inhibition compared to the individual components. Four synergistic and five additive interactions were noted. Notably, no antagonistic interactions were evident, indicating that all combinations could be used without decreasing the antibacterial activity of the components. All extracts were non-toxic in the ALA and HDF assays. Conclusion: Arctium lappa root extracts have potential as inhibitors of bacterial gastrointestinal pathogens. Furthermore, extract components may also potentiate the activity of some antibiotics that are relatively ineffective alone. Isolation and identification of these compounds may be beneficial in drug design against several gastrointestinal bacterial pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Tasmannia lanceolata (Poir.) A.C.Sm. Berry and Leaf Extracts Inhibit Proliferation and Induce Apoptosis in Selected Human Carcinoma Cell Lines.
- Author
-
Shalom, Joseph and Cock, Ian Edwin
- Subjects
- *
APOPTOSIS , *CELL lines , *ETHYL acetate , *CELL imaging , *BERRIES , *EXTRACTS - Abstract
Background: Tasmannia lanceolata berries and leaves have high antioxidant capacities and high levels of therapeutic phytochemicals. Despite this, the anticancer activity of T. lanceolata extracts has not been adequately explored. Materials and Methods: This study examined the anti-proliferative of T. lanceolata berry and leaf extracts against a panel of human carcinoma cell lines using MTS assays. The apoptotic activities were examined using cell imaging and caspase-3 activity assays. LC-MS and GC-MS headspace analysis were used to identify noteworthy phytochemical components. Results: The methanolic, aqueous and ethyl acetate extracts inhibited the proliferation of HeLa, Caco-2, Jeg-3, JAR, MC3T3-E1 and MG63 cell lines. The aqueous leaf extract was a particularly potent inhibitor of proliferation against most cell lines (HeLa IC50 = 230µg/mL; Caco-2 IC50 = 150µg/mL; Jeg-3 IC50 = 488µg/mL; JAR IC50 = 450µg/mL; MC3T3 IC50 = 195µg/mL; MG63 IC50 = 315µg/mL). The berry and leaf ethyl acetate extracts were also good inhibitors of proliferation of the same cell lines, albeit with slightly higher IC50 values. Morphological features consistent with apoptosis were evident in Caco-2 cells exposed to the berry and leaf ethyl acetate extracts, and the aqueous leaf extract. Furthermore, exposure of Caco-2 to sub-lethal concentrations of these extracts induced significantly elevated levels of caspase 3, indicating that the extracts induced apoptosis in Caco-2 cells. Conclusion: All T. lanceolata berry and leaf extracts induced apoptosis in a panel of cancer cells and were nontoxic in the ALA toxicity bioassay and in a HDF cell viability assay, supporting their potential as cancer chemotherapies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Antimicrobial Activity of Acacia disparrima Benth. and Acacia leiocalyx Pedley Leaf Extracts in Combination with Antibiotics against Bacterial Triggers of Selected Autoimmune Diseases.
- Author
-
Ruxin Guo, Xin Yang, and Cock, Ian Edwin
- Subjects
AUTOIMMUNE diseases ,ANTI-infective agents ,ACACIA ,ABORIGINAL Australians ,ANKYLOSING spondylitis - Abstract
Background: Plants of the genus Acaciahave been used by Australian Aborigines to treat a variety of conditions including bacterial pathogens and inflammation. Despite this, many Acacia spp. have not been evaluated for the ability to inhibit the growth of bacterial triggers of autoimmune inflammatory diseases. This study evaluated the effects of Acacia disparrima and Acacia leiocalyx leaf extracts alone and in combination against some bacterial triggers of rheumatoid arthritis, ankylosing spondylitis and multiple sclerosis. Results: Acacia disparrima and Acacia leiocalyx leaf extracts displayed noteworthy antibacterial activity against several bacterial triggers of autoimmune diseases. The methanolic extracts were particularly good inhibitors of P. mirabilis, K. pneumoniae, and A. baylyi with MIC values <1000µg/mL, but were ineffective against P. aeruginosa. Furthermore, combining the extracts with conventional antibiotics resulted in significant potentiation of the inhibitory activity for some combinations. Interestingly, all of the synergistic interactions contained tetracycline as the antibiotic component, whilst all of the antagonistic combinations contained either gentamicin or ciprofloxacin as the antibiotic component. None of the individual components (nor the combinations) were toxic in the ALA assay. Conclusion: The majority of combinational effects were either additive or indifferent, thereby alleviating some concern related to the concurrent use of A. disparrima and A. leiocalyx whilst also taking conventional antibiotics. A few notable combinations were identified, indicating the need for further in vivo testing. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. The prevention of fish spoilage by high antioxidant Australian culinary plants: Shewanella putrefaciens growth inhibition
- Author
-
Wright, Mitchell Henry, Matthews, Ben, Arnold, Megan Sarah Jean, Greene, Anthony Carlson, and Cock, Ian Edwin
- Published
- 2016
- Full Text
- View/download PDF
27. Phytochemistry, Medicinal Properties, Bioactive Compounds, and Therapeutic Potential of the Genus Eremophila (Scrophulariaceae).
- Author
-
Cock, Ian Edwin, Baghtchedjian, Linn, Cordon, Marie-Elisabeth, and Dumont, Eléonore
- Subjects
- *
SCROPHULARIACEAE , *BOTANICAL chemistry , *ARID regions , *BIOACTIVE compounds , *TRADITIONAL medicine , *TERPENES - Abstract
The genus Eremophila (family Scrophulariaceae) consists of approximately 200 species that are widely distributed in the semi-arid and arid regions of Australia. Multiple Eremophila spp. are used as traditional medicines by the First Australians in the areas in which they grow. They are used for their antibacterial, antifungal, antiviral, antioxidant, anti-diabetic, anti-inflammatory, and cardiac properties. Many species of this genus are beneficial against several diseases and ailments. The antibacterial properties of the genus have been relatively well studied, with several important compounds identified and their mechanisms studied. In particular, Eremophila spp. are rich in terpenoids, and the antimicrobial bioactivities of many of these compounds have already been confirmed. The therapeutic properties of Eremophila spp. preparations and purified compounds have received substantially less attention, and much study is required to validate the traditional uses and to highlight species that warrant further investigation as drug leads. The aim of this study is to review and summarise the research into the medicinal properties, therapeutic mechanisms, and phytochemistry of Eremophila spp., with the aim of focussing future studies into the therapeutic potential of this important genus. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. The Interactive Antimicrobial Activities of Selected South African Terminalia spp. Extracts in Combination with Conventional Antibiotics against Gastrointestinal Pathogens.
- Author
-
Zai, Muhammad Jawad Yousaf, Cheesman, Matthew James, and Cock, Ian Edwin
- Subjects
ANTIBIOTICS ,TERMINALIA ,ANTI-infective agents ,MEDICAL research personnel ,MEDICINAL plants ,DRUG resistance in bacteria ,BACILLUS cereus - Abstract
Background: Recent declines in new antibiotic discovery and the increase in antibiotic resistance have resulted in failing against bacterial pathogens. To develop novel antibiotic therapies, medical researchers have begun to focus on traditional therapies. Combinational therapies consisting of medicinal plants and conventional antibiotics may reactivate current drugs that are otherwise ineffective against antibioticresistant bacteria. Terminalia sericea Burch. Ex DC, Terminalia prunioides Laws. and Terminalia gazensis Bak. f. are native South African plants with antimicrobial properties. However, combinations of Terminalia sericea, Terminalia prunioides and Terminalia gazensis with conventional antibiotics are yet to be evaluated for growth inhibitory activity against gastrointestinal pathogens. Methods: Terminalia spp. leaves were extracted with solvents of varying polarity. Antimicrobial screening was performed using disc diffusion and broth microdilution assays. Toxicity was measured using Artemia franciscana nauplii lethality assays. Results: All extracts (except the T. sericea extracts) showed low to moderate inhibitory activity against B. cereus and E. faecalis, A. faecalis, A. hydrophilia, S. sonnei and S. newport in both the disc diffusion and liquid dilution assay. Twenty-three extract/antibiotic combinations produced synergy, 26 were additive, 24 were non-interactive and seven were antagonistic. Most of the antagonist interactions occurred in combinations containing gentamicin. All extracts were either non-toxic or of low toxicity in the Artemia bioassay. Conclusion: Terminalia spp. extracts may mimic the actions of a resistance modifying agents, enhancing the activity of several antibiotics that are relatively ineffective alone. Further studies are required to identify the bioactive and potentiating components and their mechanisms of action. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Growth Inhibitory Properties of Kunzea pomifera F.Muell. and Podocarpus elatus R.Br. Fruit Extracts against Axillary and Foot Odour Producing Bacteria.
- Author
-
Wood, Aiden and Cock, Ian Edwin
- Subjects
- *
FRUIT extracts , *BACTERIAL growth , *BACTERIA , *BODY odor , *PRESERVATION of fruit - Abstract
Introduction: Many high antioxidant fruit extracts can inhibit the growth of multiple bacterial pathogens. They may also inhibit the growth of malodour producing bacteria and thus be useful deodorant components, although this is yet to be tested for many Australian native fruits. Materials and Methods: Methanolic and aqueous K. pomifera and P. elatus fruit extracts were investigated by disc diffusion and liquid dilution MIC assays against the most significant bacterial contributors to axillary and plantar malodour. Toxicity was determined using Artemia franciscana nauplii bioassays and unbiased HPLC-MS QTOF analysis was used to identify interesting consituents of the most active extract. Results: Methanolic and aqueous K. pomifera and P. elatus fruit extracts displayed noteworthy bacterial growth inhibitory activity against all of the malodour forming bacteria tested. The methanolic K. pomifera extract had particularly good antibacterial effects, strongly inhibiting the growth of all bacteria, with MIC values substantially less than 1000 µg/mL. Indeed, liquid dilution (LD) MIC values of 610, 894, 663 and 625 µg/mL were recorded against C. jeikeium, P. acnes, B. linens and S. epidermidis respectively. Similar, albeit slightly higher LD MIC values were noted for the aqueous K. pomifera fruit extract, and for the methanolic and aqueous P. elatus fruit extracts against these bacteria. All K. pomifera and P. elatus fruit extracts were non-toxic in the Artemia fransiscana bioassay. Several interesting phytochemicals, including several tannins, were identified in the methanolic K. pomifera fruit extract. Conclusion: The lack of toxicity of the methanolic and aqueous K. pomifera and P. elatus fruit extracts and their noteworthy growth inhibition of axillary and plantar malodour producing bacteria indicate their potential as deodorant components. Further studies are warranted to isolate and identify the active components and to determine the antibacterial mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. The feasibility of southern African traditional plant therapies for ophthalmic use.
- Author
-
Cock, Ian Edwin, Orchard, Ané, Nhlabathi, Cynthia, Nxumalo, Thato, and Van Vuuren, Sandy
- Subjects
- *
AFRICAN traditional medicine , *EYE infections , *MACULAR degeneration , *SOUTH Africans , *PLANT species - Abstract
• One hundred and thirty eight plant species are recorded to treat eye disorders in traditional southern African medicine. • Pathogens associated with eye infections have been neglected. • Toxicity studies on many of the plant species are lacking. • No studies have focused on plant species to treat cataracts, glaucoma, macular degeneration, or diabetic retinopathy. • Sterility is a concern when administrating plant preparations directly into the eye. Ophthalmic infections are common and can cause substantial loss of eyesight. It is estimated that nearly 45% of the South African population has suffered from partial or total loss of eyesight with a substantial portion of this being due to infections. However, in approximately 80% of cases, this loss of eyesight could have been easily prevented or even treated. Multiple plant species are used in traditional South African medicine to treat eye infections, yet the therapeutic properties of most of these plants have been poorly studied. An extensive literature review of the ethnobotanical literature was undertaken to document the plant species used in southern African traditional medicine to treat eye disorders. A search was subsequently undertaken to identify and summarise studies that have provided some scientific evidence to support traditional use against these eye disorders. A total of 137 plant species belonging to 53 plant families are recorded to treat eye disorders in traditional southern African medicine. The use of many plants was credited with vague indications such as "eye problems" and "eye conditions". Only 42 of the identified species have been evaluated for inhibitory activity against any eye-related pathogens. Whilst bacterial Staphylococcal pathogens were the most extensively tested, many other pathogens associated with eye infections have been neglected. Additionally, several fungal and most viral pathogens have been completely neglected to date. Furthermore, few studies have tested the toxicity of the plant extracts and mechanistic studies are lacking. Whilst this review identifies and highlights plant species used in traditional southern African medicine to treat eye infections, substantially more research is required to completely validate their traditional use and to evaluate the potential of the plant preparations as drug leads. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Growth Inhibitory Properties of Scaevola spinescens R.Br. Leaf Extracts against the Acne Vulgaris causing Bacterium Cutibacterium acnes.
- Author
-
Cock, Ian Edwin
- Subjects
- *
CUTIBACTERIUM acnes , *ACNE , *PLANT extracts , *CHLORELLA vulgaris , *EXTRACTS , *BACTERIAL growth - Abstract
Introduction: Acne vulgaris is a skin conditions that affects most adolescents and may also afflict adults. Medicinal plant extracts may provide leads for the development of new topical and/or oral therapies for acnes vulgaris, yet many traditional medicine plants are yet to be screened for growth inhibitory activity against Cutibacterium acnes (the major bacterial cause of acne). Materials and Methods: Methanolic and aqueous Scaevola spinescens R.Br. leaf extracts were investigated by disc diffusion and liquid dilution MIC assays against Cutibacterium acnes (a significant bacterial cause of acne). Toxicity was determined using Artemia franciscana nauplii bioassays. Results: Methanolic and aqueous S. spinescens leaf extracts displayed noteworthy bacterial growth inhibitory activity against C. acnes growth. The aqueous S. spinescens leaf extract had particularly good antibacterial effects against C. acnes, with an LD MIC value of 344 μg/mL. Similar, albeit slightly higher LD MIC values were noted for the aqueous methanolic S. spinescens leaf extract against C. acnes (LD MIC = 875 μg/mL). The methanolic and aqueous S. spinescens leaf extracts were nontoxic in the Artemia fransiscana bioassay, with LC50 values substantially >1000 μg/mL. Conclusion: The lack of toxicity of the methanolic and aqueous S. spinescens leaf extracts and their noteworthy growth inhibition of C. acnes indicate their potential as treatments to alleviate acne vulgaris. Further studies are warranted to isolate and identify the active components and to determine their antibacterial mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. The Effects of Storage Time on the Antibacterial Activity of Terminalia sericea Burch. ex DC. Extracts.
- Author
-
Hongcheng Zhu, Shalom, Joseph, and Cock, Ian Edwin
- Subjects
ANTIBACTERIAL agents ,DRUG resistance in bacteria ,TERMINALIA ,EXTRACTS ,DRUG discovery - Abstract
Introduction: The recent development of extensively antibiotic resistant bacteria has necessitated the search for novel antibacterial therapies. An examination of aromatic plants and traditional medicines is an attractive option for drug discovery. Terminalia sericea Burch. ex DC. is a southern African native species, which has been reported to have antibacterial activity, although the effects of storage on the activity is yet to be determined. Materials and Methods: The ability of T. sericea leaf extracts to inhibit the growth of a panel of bacterial triggers of autoimmune diseases was quantified by disc diffusion and liquid dilution MIC assays. The potency of extracts prepared using fresh and stored leaves was compared. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: The T. sericea leaf methanolic and aqueous extracts displayed noteworthy growth inhibitory activity towards all bacterial pathogens tested. However, a substantial decrease in activity was seen when extracts were prepared using leaves that had been stored for two years, indicating that the leaves become less useful therapeutically over time. All extracts were non-toxic in the Artemia nauplii bioassay following 24hr exposure. Conclusion: The T. sericea leaf extracts had noteworthy antibacterial activity, although the potency decreased substantially following storage of the leaf material. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Potential of Traditional Chinese Medicines to treat Drug-resistant Bacterial Infections: A Review.
- Author
-
Cao, Ziang and Cock, Ian Edwin
- Subjects
- *
CHINESE medicine , *BACTERIAL diseases , *HERBAL medicine , *MULTIDRUG resistance , *DRUG resistance in bacteria - Abstract
Background: Antibiotic drugs have been widely applied in the treatment of bacterial infections. However, with the overuse and unreasonable adoption of antibiotics, a variety of bacteria have developed resistance to commonly used antibiotics. Bacterial pathogens with multi-drug resistance mechanisms have made many infectious diseases more difficult to be treat and new therapies are urgently needed. Methods: An extensive review of ethnobotanical books, reviews and primary scientific studies was undertaken to identify TCMs used to treat bacterial infections and the individual components of those medicines this information was used to identify gaps in the current research that require further study. Results: Traditional Chinese medicine contain multiple components and function via multiple pathways against multiple targets. Many of these pathways and concepts may be difficult for non-Chinese due to their complexities. However, an evaluation of TCMs for antibacterial activities is an attractive option for antibiotic discovery and development as they generally have low toxicity, low side effects and as combinational therapies, there is no inherent drug resistances in human bacterial pathogens towards these drugs. This study reviews the current status of bacterial resistance, the mechanism of traditional Chinese medicine against bacterial infections, and the adoption progress of Chinese herbal medicines in the treatment of resistant bacterial infections. Conclusion: TCM can inhibit the growth of bacterial pathogens and can participate in mediating the immune function of multiple bodily aspects. Therefore, Chinese herbal medicine may provide new leads to treat drug-resistant bacterial infections. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. Arctium lappa L. Root Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases and Potentiate the Activity of Conventional Antibiotics.
- Author
-
Zhao, Nan, Wang, Lejia, and Cock, Ian Edwin
- Subjects
AUTOIMMUNE diseases ,BACTERIAL growth ,ANTIBIOTICS ,PEPTIDE antibiotics ,ANTIBACTERIAL agents ,RHEUMATOID arthritis ,ETHYL acetate - Abstract
Introduction: An increase in antibiotic resistance and a corresponding decrease in antimicrobial discovery have directed researchers towards alternative therapies, including plant based medicines. However, synergistic combinations of plant extracts with conventional antibiotics may be a far more effective approach in overcoming resistance and potentiating the activity of antibiotics that are otherwise ineffective against resistant bacterial strains. Methods: The antibacterial activity of Arctium lappa L. root extracts was investigated by disc diffusion and quantified by liquid dilution and solid phase MIC assays. The extracts were also combined with a range of conventional antibiotics and tested against various microbial triggers of autoimmune diseases. The ΣFIC values obtained from these assays were used to determine the class of combinational effects. Toxicity was evaluated by Artemia nauplii mortality and HDF cytotoxicity assays. Results: Methanolic and ethyl acetate A. lappa root extracts showed good inhibitory activity against several microbial triggers of autoimmune inflammatory diseases, including P. mirabilis, P. vulgaris and A. baylyi. The aqueous extract was also a noteworthy inhibitor of A. baylyi growth. Of further interest, some combinations of the A. lappa root extracts and conventional antibiotics potentiated bacterial growth inhibition compared to the individual components alone. One synergistic and six additive interactions were noted. Notably, no antagonistic interactions were evident, indicating that all combinations could be used without decreasing the antibacterial activity of the components. All extracts were nontoxic in the ALA and HDF assays. Conclusion: Arctium lappa L. root extracts have potential as inhibitors of bacterial triggers of selected autoimmune inflammatory diseases. Furthermore, extract components may also potentiate the activity of three antibiotics that are relatively ineffective alone. Isolation and identification of these compounds may be beneficial in drug design against several bacteria, including the microbial triggers of rheumatoid arthritis and multiple sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Combinational Inhibitory Effects of Terminalia arjuna (Roxb.) Wight and Arn. Extracts and Conventional Antibiotics against Bacterial Triggers of Selected Inflammatory Diseases.
- Author
-
Han Ye and Cock, Ian Edwin
- Subjects
- *
TERMINALIA arjuna , *CHLOROFORM , *ANTIBIOTICS , *CIPROFLOXACIN , *ETHYL acetate , *EXTRACTS , *DRUG design , *ANTI-infective agents - Abstract
Introduction: Terminalia arjuna (Roxb.) Wight and Arn. is a southern Asian plant commonly used in Ayurveda to treat multiple conditions, including for the treatment of inflammation, and as a general antimicrobial agent. Despite this, few studies have tested this species for the ability to block the growth of bacterial triggers of some autoimmune inflammatory diseases. Furthermore, the ability of T. arjuna to potentiate the activity of conventional antibiotics is yet to be investigated. Materials and Methods: The minimum inhibitory concentration of the extracts and extract-antibiotic combinations was determined by disc diffusion and liquid dilution MIC methods. Fractional inhibitory concentration values were calculated to evaluate the combinational effect of combinations of extracts and conventional antibiotics. When synergistic interactions were detected, isobologram analysis was used to determine the ideal ratios for synergy. Toxicity was evaluated by Artemia nauplii mortality and HDF cell viability assays. Results: Methanolc, aqueous and ethyl acetate T. arjuna extracts were good inhibitors of P. mirabilis and K. pneumoniae growth when tested alone. The methanolic and aqueous extracts also synergised the inhibitory activity of ciprofloxacin against P. mirabilis and K. pneumoniae when used in combination. Additionally, numerous additive combinational effects were noted. T. arjuna chloroform extract was also a moderate inhibitor of a multi-drug resistant P. aeruginosa strain when tested alone, but did not potentiate the activity of any of the conventional antibiotics tested. All extracts and extract-antibiotic combinations were nontoxic in the Artemia nauplii mortality and HDF proliferation assays, indicating their suitability for therapeutic use. Conclusion: T. arjuna extracts have potential as inhibitors of bacterial triggers of selected autoimmune inflammatory diseases. Furthermore, T. arjuna extracts potentiate the activity of ciprofloxacin against P. mirabilis and K. pneumoniae and therefore may be beneficial in drug design against these bacteria. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. Heritiera actinophyllum (F.M.Bailey) Kosterm. Leaf Extracts Lack Antibacterial Activity and are non-toxic in vitro.
- Author
-
Cock, Ian Edwin
- Subjects
- *
EXTRACTS , *NATIVE plants , *GRAM-negative bacteria , *MEDICAL research , *ANTI-infective agents - Abstract
Introduction: The development of bacterial strains that are resistant to multiple antibiotics has made the discovery of new antibiotics a priority for medical research. Examination of plants for new antimicrobial agents is an attractive prospect and numerous recent studies have screened plants for antibacterial activity. Despite this, Australian native plants have been relatively neglected. Heritiera actinophyllum (F.M.Bailey) Kosterm. is a rainforest tree that is native to eastern coastal regions of Australia. Material from this species has not yet been examined for antibacterial properties against human pathogens. Materials and Methods: The ability of H. actinophyllum leaf extracts to inhibit the growth of a panel of bacterial pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: H. actinophyllum methanolic and aqueous extracts were ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria. The extracts were non-toxic or of low toxicity following 24 h exposure. Conclusion: The H. actinophyllum leaf extracts lacked growth inhibitory bioactivity against a panel of pathogenic bacteria and were nontoxic in the Artemia nauplii assay. However, these extracts may have other therapeutic properties and testing against protozoa, fungi, and virus and tumour cells is required. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Chemical Composition, Antibacterial Activity, and Antibiotic Potentiation of Boswellia sacra Flueck. Oleoresin Extracts from the Dhofar Region of Oman.
- Author
-
Rashan, Luay, White, Alan, Haulet, Manon, Favelin, Nicolas, Das, Parag, and Cock, Ian Edwin
- Subjects
ANTIBIOTICS ,DRUG-herb interactions ,GUMS & resins ,MOLECULAR biology ,PHYTOCHEMICALS ,CELL survival ,HYDROCARBONS ,DRUG synergism ,PLANT extracts - Abstract
The emergence of MDR bacterial pathogens has directed antibiotic discovery research towards alternative therapies and traditional medicines. Boswellia sacra oleoresin (frankincense) was used to treat bacterial infections in traditional Arabian and Asian healing systems for at least 1000 years. Despite this, B. sacra extracts have not been rigorously tested for inhibitory activity against gastrointestinal pathogens or bacterial triggers of autoimmune diseases. Solvent extracts were prepared from Boswellia sacra oleoresins obtained from three regions near Salalah, Oman. MIC values were quantified against gastrointestinal pathogens and bacterial triggers of selected autoimmune diseases by disc diffusion and broth dilution methods. The antibacterial activity was also evaluated in combination with conventional antibiotics, and the class of interaction was determined by ΣFIC analysis. Isobolograms were used to determine the optimal ratios for synergistic combinations. Toxicity was evaluated by ALA and HDF cell viability bioassays. The phytochemical composition of the volatile components of all extracts was identified by nontargeted GC-MS headspace analysis. All methanolic extracts inhibited the growth of all of the bacteria tested, although the extracts prepared using Najdi oleoresin were generally more potent than the Sahli and Houjari extracts. Combinations of the methanolic B. sacra extracts and conventional antibiotics were significantly more effective in inhibiting the growth of several bacterial pathogens. In total, there were 38 synergistic and 166 additive combinations. Approximately half of the synergistic combinations contained tetracycline. All B. sacra extracts were nontoxic in the ALA and HDF cell viability assays. Nonbiased GC-MS headspace analysis of the methanolic extracts putatively identified a high diversity of monoterpenoids, with particularly high abundances of α-pinene. The antibacterial activity and lack of toxicity of the B. sacra extracts indicate their potential in the treatment and prevention of gastrointestinal and autoimmune diseases. Furthermore, the extracts potentiated the activity of several conventional antibiotics, indicating that they may contain resistance-modifying compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Mirbelia oxylobioides F. Muell. Leaf Extracts Lack Antibacterial Activity and are Non-toxic in vitro.
- Author
-
Cock, Ian Edwin
- Subjects
- *
EXTRACTS , *PATHOGENIC bacteria , *NATIVE plants , *GRAM-negative bacteria , *MEDICAL research - Abstract
Introduction: The development of bacterial strains that are resistant to multiple antibiotics has made the discovery of new antibiotics a priority for medical research. Examination of plants for new antimicrobial agents is an attractive prospect and numerous recent studies have screened plants for antibacterial activity. Despite this, Australian native plants have been relatively neglected. Mirbelia oxylobioides F. Muell. is a native Australian shrub of the family Fabaceae. Very few studies have yet examined species for antibacterial properties against human pathogens. Methods: The ability of M. oxyloboides leaf extracts to inhibit the growth of a panel of bacterial pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: M. oxyloboides methanolic and aqueous extracts were ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria. The extracts were non-toxic or of low toxicity following 24 h exposure. Conclusion: The M. oxyloboides leaf extracts lacked growth inhibitory bioactivity against a panel of pathogenic bacteria and were non-toxic in the Artemia nauplii assay. However, these extracts may have other therapeutic properties and testing against protozoa, fungi, virus and tumour cells is required. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Kunzea ambigua (Sm.) Druce and Kunzea flavescens C.T. White and W.D. Francis Essential Oils Inhibit the Growth of Some Bacterial Triggers of Inflammatory Diseases.
- Author
-
Barillot, Célia and Cock, Ian Edwin
- Subjects
- *
BACTERIAL growth , *BACTERIAL diseases , *PATHOGENIC bacteria , *ENDEMIC plants , *ARTEMIA , *ESSENTIAL oils - Abstract
Introduction: Kunzea ambigua (Sm.) Druce and Kunzea flavescens C.T. White and W.D. Francis are endemic Australian plants. Decoctions, infusions and essential oils produced from the leaves were used traditionally to treat a variety of bacterial diseases. Despite this, these species have not been rigorously examined for antibacterial properties against many pathogens. Methods: The antimicrobial activity of K. ambigua and K. flavescens essential oils and a K. ambigua hydrosol was investigated by disc diffusion and liquid dilution MIC assays against a panel of pathogenic bacteria. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: K. ambigua and K. flavescens essential oils displayed noteworthy growth inhibitory activity against A. baylyi, K. pneumonia, P. mirabilis and P. aeruginosa (MIC values substantially <1000μg/mL). Indeed, MIC values as low as 33μg/mL were noted against P. aeruginosa. Noteworthy growth inhibitory activity was also noted for the K. ambigua hydrosol against A. baylyi and P. aeruginosa. All extracts were determined to be non-toxic in the Artemia franciscana nauplii bioassay, indicating their safety for internal use as well as for topical uses. Conclusion: The lack of toxicity of the Kunzea spp. extracts and their growth inhibitory bioactivity against a panel of pathogenic bacteria partially validate the traditional usage of these species to treat bacterial diseases and indicate their potential in the development of antiseptic agents. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Evaluating the Antimicrobial Potential of Eucalyptus baileyana F. Muell. and Eucalyptus major (Maiden) Blakely against the Fish Spoilage-causing Bacterium Shewanella putrefaciens.
- Author
-
Wright, Mitchell Henry, Greene, Anthony Carlson, and Cock, Ian Edwin
- Subjects
SHEWANELLA putrefaciens ,EUCALYPTUS ,FISH spoilage ,PLANT-water relationships ,MICROBIAL growth ,SOLVENT extraction - Abstract
Introduction: Eucalyptus baileyana (Bailey's stringy bark) and Eucalyptus major (Queensland grey gum) have been previously used as antimicrobials against a variety of ailments. This study evaluated the effectiveness of E. baileyana and E. major as inhibitory agents against Shewanella putrefaciens, a bacterium widely associated with fish spoilage. Methodology: E. baileyana and E. major extracts were prepared using the leaves of each plant with methanol or water as the extraction solvent. Growth inhibition and minimal inhibitory concentrations were determined against S. putrefaciens through disc diffusion assays. MIC values were subsequently quantified to evaluate the extracts efficacies as antibacterial agents. Finally, the toxicity of each extract was determined using the Artemia franciscana nauplii bioassay. Results: E. baileyana aqueous and methanolic leaf extracts inhibited the growth of S. putrefaciens in the disc diffusion assay, with MIC values of 1411 and 1221 μg/mL respectively. Similarly, E. major leaf extracts also showed growth inhibition of S. putrefaciens, with MIC values of 1686 μg/mL for the aqueous extract, and 1160 μg/mL for the methanolic extract. However, toxicity studies of the extracts revealed that all extracts were toxic and likely unsuitable for human consumption (LC50 values 455-1146 μg/mL) as determined by the Artemia franciscana bioassay. Conclusion: While the E. baileyana and E. major leaf extracts were effective in preventing microbial growth, given their relatively high levels of toxicity, they would not be suitable for use as a preservative in the prevention of fish spoilage. However, the antibacterial capacity of the extracts indicates that the extracts may show promise as a surface disinfectant, and this should be investigated further. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Anti-proliferative Activity of Hibiscus sabdariffa L. Calyx Flavonoid Extracts on Cervical Cancer Cells using Flow Cytometry.
- Author
-
Aina, Temilola, Akpe, Victor, Magbagbeola, Olubunmi, and Cock, Ian Edwin
- Subjects
CERVICAL cancer ,ROSELLE ,CANCER cells ,FLOW cytometry ,CANCER cell proliferation ,FLAVONOIDS ,PAPILLOMAVIRUS diseases ,ETHYL acetate - Abstract
Background: Impairment of the normal progression of the cell cycle affects the growth and development of the daughter cells, which may result in cancer cell proliferation. Herein, we investigate the effect of flavonoid fractions of Hibiscus sabdariffa L. calyx on cell cycle progression in cervical cancer cells. Methods: Flavonoids (bound and free), lipids and aqueous fractions were extracted from a methanolic extract of H. sabdariffa calyx using ethyl acetate, diethyl ether and petroleum ether. Each of these fractions were used to treat HeLa cervical cancer cells and monitored using a flow cytometer. Results: The cells exposed to the extract and its fractions had higher percentages of inactive cells (no cell division) at the quiescent (G0) and gap one phases (G1) of the cell cycle in comparison to control cells. The highest values were obtained from cells treated with the bound and free flavonoid fractions. Conclusion: The results of this study suggest that HeLa cervical cancer cell proliferation is significantly inhibited by H. sabdariffa flavonoid fractions. Daily consumption of beverages consisting of H. sabdariffa may therefore prevent the early stages of cervical cancer and inhibit the progression of the disease once it is established. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. An Examination of the Antioxidant Capacity, Antibacterial Activity and Toxicity of Commercial Kale and Spirulina Powders.
- Author
-
Blanc, Clémence and Cock, Ian Edwin
- Subjects
- *
SPIRULINA , *OXIDANT status , *KALE , *DIFFUSION , *POWDERS , *SILVER nanoparticles , *IRINOTECAN - Abstract
Introduction: The development of antibiotic resistant bacteria has resulted in treatment failure for the current antibiotic regimen against many bacteria. A corresponding decrease in the development of new antibiotic therapies has highlighted the urgent need for the discovery of new antibiotics. An examination of 'superfoods' is an attractive option due to the high antioxidant capacities and beneficial secondary compounds reported in many 'superfoods'. This study was undertaken to test kale and spirulina extracts for the ability to inhibit the growth of a panel of bacterial pathogens of human importance. Methods: Commercially sourced kale and spirulina powders were extracted and tested for antimicrobial activity using modified disc diffusion and liquid dilution MIC methods. Toxicity was evaluated using an Artemia franciscana nauplii bioassay. Results: The methanolic and aqueous extracts of kale and spirulina displayed noteworthy growth inhibitory activity against P. mirabilis. The aqueous spirulina extract was a particularly good inhibitor of P. mirabilis, with MIC values as low as 220µg/mL. In contrast, all extracts were ineffective or of low inhibitory activity against all other bacteria tested. All extracts were non-toxic in the Artemia nauplii bioassay, confirming their suitability as natural antibacterial therapies. Conclusion: These studies indicate that aqueous kale and spirulina extracts are promising inhibitors of P. mirabilis growth and may be useful in the prevention and treatment of rheumatoid arthritis, as well as other diseases caused by that bacterium. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Astrotrichia latifolia Benth. Leaf Extracts Lack Antibacterial Activity and are Non-toxic in vitro.
- Author
-
Mpala, Lindiwe Nomathemba, Chikowe, Getmore Rumbudzai, and Cock, Ian Edwin
- Subjects
TYPHA latifolia ,BACTERIAL growth ,EXTRACTS ,AROMATIC plants ,GRAM-negative bacteria ,TRADITIONAL medicine - Abstract
Introduction: The recent development of extensively antibiotic resistant bacteria has necessitated the search for novel antibacterial compounds. An examination of aromatic plants and traditional medicines is an attractive option for drug discovery. Astrotrichia latifolia Benth. is a native Australia shrub that has yet to be tested for antibacterial activity. Methods: The ability of A. latifolia leaf extracts to inhibit the growth of a panel of bacterial pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: A. latifolia leaf methanolic and aqueous extracts were completely ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria. The extracts were non-toxic in the Artemia nauplii bioassay following 24 h exposure. Conclusion: A. latifolia leaf extracts were completely ineffective bacterial growth inhibitors. However, these extracts may have other therapeutic properties and testing against protozoa, virus and tumour cells is required. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. The Therapeutic Properties of Plants Used Traditionally to Treat Gastrointestinal Disorders on Groote Eylandt, Australia.
- Author
-
Mazerand, Cécile and Cock, Ian Edwin
- Subjects
- *
BACTERIAL disease treatment , *GASTROINTESTINAL disease treatment , *PHYTOTHERAPY , *VIRAL disease treatment , *THERAPEUTIC use of eucalyptus , *CELL proliferation , *ANTIVIRAL agents , *CELL lines , *CHALONES , *COLON tumors , *DIARRHEA , *MEDICAL screening , *PROTOZOA , *STAPHYLOCOCCUS aureus , *THERAPEUTICS , *TOXICITY testing , *TRADITIONAL medicine , *CELL survival ,THERAPEUTIC use of plant extracts ,RECTUM tumors ,CERVIX uteri tumors - Abstract
The First Australians had well-developed healing systems. Groote Eylandt inhabitants used a variety of plant species to treat diarrhoea and other gastrointestinal illnesses. This study was undertaken to test, identify, and evaluate traditional medicines to treat these conditions against gastrointestinal bacterial, protozoal, and viral pathogens, as well as against cancer cell proliferation. Six plant species (Buchanania obovata Engl., Casuarina equisetifolia L., Eucalyptus tetrodonta F. Muell., Planchonia careya (F. Muell.) R. Knuth, Terminalia carpentariae C. T. White, and Vigna vexillata (L.) A. Rich.) were selected from a survey of a panel of elders from the Warnindhilyagwa tribe and compared with the published literature. Decoctions prepared according to traditional methods were screened for growth inhibitory activity of a panel of diarrhoea-causing bacterial pathogens by disc diffusion and liquid dilution MIC assays. Inhibitory activity against the gastrointestinal protozoal parasite Giardia duodenalis and antiproliferative activity against human colorectal (Caco2) and cervical (HeLa) cancer cell lines were evaluated using MTS-based colorimetric cell proliferation assays. Preliminary antiviral screening was accomplished using an MS2 bacteriophage plaque reduction assay. Toxicity was evaluated using Artemia franciscana nauplii mortality and HDF cell viability bioassays. All traditional medicines tested inhibited bacterial growth, often with MIC values substantially <1000 μg/mL. T. carpentariae was particularly noteworthy, with MIC values of 230–350 μg/mL against Citrobacter freundii, Salmonella newport, Shigella sonnei, Staphylococcus aureus, and Staphylococcus epidermidis. This species also had MICs 450–950 μg/mL against all other bacterial pathogens. B. obovata Engl. and E. tetrodonta were also good inhibitors of bacterial growth, albeit with substantially higher MIC values than determined for T. carpentariae. The T. carpentariae decoction was also the best inhibitor of MS2 phage replication (IC50 = 427 μg/mL) and Caco2 and HeLa proliferation (IC50 values of 885 and 85 μg/mL, respectively). None of the extracts were particularly strong inhibitors of Giardia duodenalis growth. All decoctions were nontoxic in the Artemia nauplii and HDF cell viability bioassays, indicating their suitability for therapeutic use. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Inertial Microfluidic Purification of Floating Cancer Cells for Drug Screening and Three-Dimensional Tumor Models.
- Author
-
Zhang, Jun, Chintalaramulu, Naveen, Vadivelu, Raja, An, Hongjie, Yuan, Dan, Jin, Jing, Ooi, Chin Hong, Cock, Ian Edwin, Li, Weihua, and Nguyen, Nam-Trung
- Published
- 2020
- Full Text
- View/download PDF
46. Trachiyspirum ammi (L.) Sprague ex Turrill Seed Extracts Lack Antibacterial Activity.
- Author
-
Zai, Muhammad Jawad Yousaf and Cock, Ian Edwin
- Subjects
- *
GRAM-negative bacteria , *ETHYL acetate , *HEXANE , *SEEDS , *EXTRACTS , *BACTERIAL growth - Abstract
Introduction: Trachyspermum ammi leaves and seeds have been used as dietary supplements and to treat multiple pathogenic diseases in several traditional healing systems. Despite this, their therapeutic properties have been poorly studied. Methods: Chloroform, ethyl acetate, hexane, methanol and water extracts of T. ammi were prepared and tested and the activity was compared to that of standard antibiotics for their in vitro antibacterial activity against ten human bacterial pathogens. The antibacterial activity was studied by standard disc diffusion assays and the activity was recorded as zones of inhibition. Results: All T. ammi seed extracts were ineffective at inhibiting the growth of all of the gram-positive and gram-negative bacteria pathogens screened against. Conclusion: Despite their use in traditional healing systems to treat some pathogenic diseases, T. ammi seed extracts were completely ineffective bacterial growth inhibitors. However, these extracts were screened against a limited panel of bacteria and further testing against other pathogens is required. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. Centella asiatica (L.) Urban Leaf Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases and Potentiate the Activity of Conventional Antibiotics.
- Author
-
Yan Zhang, Zihao Yang, and Cock, Ian Edwin
- Subjects
CENTELLA asiatica ,AUTOIMMUNE diseases ,CHLOROFORM ,BACTERIAL growth ,PEPTIDE antibiotics ,ANTIBIOTICS ,DRUG resistance in bacteria ,TETRACYCLINES - Abstract
Introduction: An increase in antibiotic resistance and a corresponding decrease in antimicrobial discovery have directed researchers towards alternative therapies, including plant based medicines. However, synergistic combinations of plant extracts with conventional antibiotics may be a far more effective approach in overcoming resistance and potentiating the activity of antibiotics that are otherwise ineffective against resistant bacterial strains. Methods: The antibacterial activity of Centella asiatica (Gotu Kola) extracts was investigated by disc diffusion and quantified by liquid dilution and solid phase MIC assays. The extracts were also combined with a range of conventional antibiotics and tested against various microbial triggers of autoimmune diseases. The SFIC values obtained from these assays were used to determine the class of combinational effects and isobologram analysis was used to determine the ideal synergistic ratio(s). Toxicity was evaluated by Artemia nauplii mortality assays. Results: The methanolic extracts showed good inhibitory activity against several microbial triggers of autoimmune inflammatory diseases, whilst the chloroform and hexane extracts were also potent inhibitors of K. pneumoniae growth. Combinations of the C. asiatica extracts with conventional antibiotics were often substantially more effective in inhibiting bacterial growth. One synergistic and 10 additive interactions were noted. Notably, the methanolic extract restored significant growth inhibitory activity to chloramphenicol and tetracycline when tested in combination against K. pneumoniae. In contrast, two antagonistic interactions were noted for combinations containing gentamycin (against A. baylyi and S. pyogenes), indicating that those combinations should be avoided when treating infections caused by those bacteria. Conclusion: C. asiatica extracts have potential as inhibitors of bacterial triggers of selected autoimmune inflammatory diseases. Furthermore, extract components may also potentiate the activity of two antibiotics that are relatively ineffective alone. Isolation of these agents may be beneficial in drug design against several bacteria, including the microbial triggers of rheumatoid arthritis, ankylosing spondylitis and multiple sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
48. Davidsonia pruriens F. Muell. Fruit and Leaf Extracts Lack Antibacterial and Antifungal Activity.
- Author
-
Mpala, Lindiwe, Chikowe, Getmore, and Cock, Ian Edwin
- Subjects
FRUIT extracts ,BACTERIAL growth ,OXIDANT status ,FUNGAL growth ,ANTIFUNGAL agents ,GRAM-negative bacteria - Abstract
Introduction: High antioxidant levels have been linked with multiple therapeutic properties, including antibacterial activity. Therefore, high antioxidant plant preparations are good targets for antibacterial testing. D. pruriens has high antioxidant capacity although it is yet to be tested for the ability to inhibit the growth of bacterial pathogens. Methods: The ability of D. pruriens fruit and leaf extracts to inhibit the growth of a panel of bacterial and fungal pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: All D. pruriens fruit and leaf extracts were completely ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria, as well as fungi. The extracts were non-toxic in the Artemia bioassay following 24 h exposure. Conclusion: Despite their high antioxidant capacity, D. pruriens fruit and leaf extracts were completely ineffective bacterial and fungal growth inhibitors. However, these extracts may have other therapeutic properties and testing against protozoa, virus and tumour cells is required. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
49. Tabebuia impetiginosa (Mart. Ex DC. Mattos) Bark Extracts Inhibit the Growth Gastrointestinal Bacterial Pathogens and Potentiate the Activity of some Conventional Antibiotics.
- Author
-
Fernandez, Alejandra and Cock, Ian Edwin
- Subjects
- *
ANTIBIOTICS , *CIPROFLOXACIN , *TRICHODERMA , *BACTERIAL growth , *BARK , *BACILLUS cereus , *DIFFUSION - Abstract
Introduction: Tabebuia impetiginosa (Mart. Ex DC. Mattos) bark has been used to treat inflammation and cancer, as well as a variety of pathogenic diseases, in traditional South American healing systems. As practitioners of complementary medicine frequently use herbal medicines concurrently with conventional antibiotics, the effects of both therapies in combination needs to be evaluated. Methods: The growth inhibitory activity of T. impetiginosa bark extracts was assessed against a panel of gastrointestinal bacterial pathogens by standard disc diffusion and liquid dilution minimum inhibitory concentration (MIC) methods. Combinational effects between the extracts and conventional antimicrobials were classified using the sum of the fractional inhibitory concentration. The toxicity of the individual samples and combinations was evaluated by Artemia lethality and MTS HDF cell viability assays. Results: T. impetiginosa bark extracts strongly inhibited the growth of B. cereus but were ineffective against Escherichia coli, Shigella sonnei, Staphylococcus aureus. The mid polarity ethyl acetate extract was a particularly good inhibitor of B. cereus growth (DD and LD MIC values of 45 and 245 µg/mL respectively). However, the effects of combinations of the extracts and conventional antibiotics was of considerably more interest. Although no synergistic interactions were noted, the potency of some combinations were substantially potentiated compared to activity of the individual components. Additive potentiation was was noted for combinations containing the T. impetiginosa water extract and erythromycin, chloramphenicol or penicillin-G against E. coli and S. aureus. Combinations containing ciprofloxacin also produced additive effects against all of the bacteria tested. Therefore, these combinations have enhanced benefits over either component alone. Of further note, antagonistic interactions were also detected in several combinations containing ciprofloxacin (particularly against S. aureus). These combinations should therefore be avoided against that bacterium. Conclusion: T. impetiginosa bark extracts inhibit the growth of B. cereus when tested alone and potentiated the activity of some conventional antibiotics against a panel of gastrointestinal pathogens when used in combination. Thus, T. impetiginosa bark extracts have potential in the treatment of diarrhoea and other gastrointestinal diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Alphitonia excelsa (Fenzl) Benth. Leaf Extracts Inhibit the Growth of a Panel of Pathogenic Bacteria.
- Author
-
Cock, Ian Edwin
- Subjects
- *
PATHOGENIC bacteria , *BACILLUS cereus , *GRAM-negative bacteria , *BACTERIAL diseases , *SOLVENT extraction , *ETHYL acetate - Abstract
Introduction: Alphitonia excelsa (Fenzl) Benth. is a large tree that is native to the east coast and northern regions of Australia. Decoctions and infusions produced from the leaves were used by the first Australians to treat a variety of bacterial diseases. Despite this, A. excelsa leaf extractions have not been rigorously examined for antibacterial properties against many pathogens. Methods: The antimicrobial activity of A. excelsa leaf extractions was investigated by disc diffusion and growth time course assays against a panel of pathogenic bacteria. The growth inhibitory activity was quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Polar to mid-polarity A. excelsa leaf solvent extractions inhibited the growth of a wide range of bacterial species. Growth of both gram positive and gram negative bacteria was inhibited by the A. excelsa leaf extracts to approximately the same extent. The methanolic extracts were the most potent growth inhibitor against all bacteria tested. The methanolic, aqueous and ethyl acetate A. excelsa leaf extracts were particularly potent inhibitors of P. mirabilis growth, with MIC values as low as 118µg/mL for the methanolic extract. A. hydrophilia, E. coli, K. pneumonia, S. marcenscens and B. cereus were also particularly susceptible to the methanolic extract, with MIC values generally substantially <1000 µg/mL. The antibacterial activity of the methanolic A. excelsa leaf extract was further investigated by growth time course assays which showed significant growth inhibition in cultures of P. mirabilis and B. cereus within 1 h of exposure. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for internal use as well as for topical uses. Conclusion: The lack of toxicity of the A. excelsa leaf extracts and their growth inhibitory bioactivity against a panel of pathogenic bacteria partially validate the traditional usage of this species to treat bacterial diseases and indicate their potential in the development of antiseptic agents. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.